Endpoints of clinical trials for muscle-invasive bladder cancer
Tannock, I.F.
Progress in Clinical and Biological Research 353: 65-74
1990
ISSN/ISBN: 0361-7742 PMID: 2217428 Document Number: 362820
Document emailed within 1 workday
Related Documents
Nakajima, T.; Ohta, K.; Ohyama, S.; Yamaguchi, T. 2000: Surrogate and true endpoints in cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(5): 671-675Miyazaki, J. 2018: IIi .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 33-37
Ericson, K.J.; Murthy, P.B.; Bryk, D.J.; Ramkumar, R.R.; Broughman, J.R.; Khanna, A.; Mian, O.Y.; Campbell, S.C. 2019: Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer Clinical Advances in Hematology and Oncology: H&o 17(12): 697-707
Chantada-Abal, V.; Chantada-Tirado, C.; Lamas-Díaz, L.; Caramés-Masana, F.; Villegas-Piguave, A.D.án.; Villar-Vázquez, N. 2018: Sequential treatment with Mitomycin C and BCG in non muscle invasive bladder cancer Archivos Espanoles de Urologia 71(4): 453-457
Henry, N.L.; MacVicar, G.; Hussain, M. 2005: Management of patients with muscle-invasive and metastatic bladder cancer Oncology 19(10): 1333-1342; Discussion 1342 1347 1350 Passim
Tian, Y. 2012: Attach importance to the chemotherapy of muscle invasive bladder cancer Zhonghua Yi Xue Za Zhi 92(6): 363-365
Gontero, P.; Fiorito, C.; Lucca, I.; Valentino, F.; Tizzani, A. 2008: New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 80(4): 162-166
Kikuchi, E.; Oya, M. 2014: II. Urothelial carcinoma-current topics and treatment for non-muscle invasive bladder cancer- Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(1): 42-46
Izawa, J.I.; Chin, J.L.; Winquist, E. 2006: Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer Canadian Journal of Urology 13(Suppl 3): 48-53
Boscolo-Berto, R.; Viel, G.; Lamon, C.; Agostini, A.; Vezzaro, R.; Gardiman, M.; Montisci, M.; Raduazzo, D.I. 2011: Giant scrotal lymphedema as unique onset sign of muscle-invasive bladder cancer. the risk of a misdiagnosis Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 83(2): 95-98
Kida, K.; Shimizu, Y.; Ogawa, K.; Kanamaru, S.; Ito, N. 2018: Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases Hinyokika Kiyo. Acta Urologica Japonica 64(6): 271-275
Sanjo, H.; Ito, Y.; Osaka, K.; Komiya, A.; Kobayashi, K.; Sakai, N.; Noguchi, S.; Kishi, H. 2012: Metastatic micropapillary variant of the urinary bladder: progression from low grade non-muscle invasive bladder carcinoma Hinyokika Kiyo. Acta Urologica Japonica 58(8): 447-451
Krummenauer, F. 2017: Multiple endpoints in clinical trials – severe adverse event potentials from the medical biometrician's perspective Medizinische Monatsschrift für Pharmazeuten 40(5): 209-213
Cao, M.; Ma, C.-k.; Ma, J.; Chen, H.-g.; Xue, W. 2011: Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer Zhonghua Zhong Liu Za Zhi 33(5): 385-387
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Held, J.; Volpe, H. 1991: Bladder preserving combined modality therapy for invasive bladder cancer Oncology Nursing Forum 18(1): 49-57
Krijnen, P.; Bos, M.M.E.M.; Kloosterman-Boele, W.M.; Bevers, R.F.M. 2011: Variations in the treatment of non-metastatic muscle-invasive bladder carcinoma Nederlands Tijdschrift Voor Geneeskunde 155: A2703
Rolevich, A.I.; Evmenenko, A.A. 2016: A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral resect Urologiia 2016(4): 137-146
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323